Abstract:Topical therapies for chronic skin diseases suffer from a low patient compliance due to the inconvenient treatment regimens of available products. Dissolvable microneedles (MN) with modified release offer an interesting possibility to increase the compliance by acting as a depot in the skin and thereby decreasing the dosing frequency. Furthermore, the bioavailability can be increased significantly by bypassing the barrier of the skin by the direct penetration of the MN into the skin. In this study the depot effect and skin penetration of an innovative dissolvable MN patch was assessed by insertion in ex vivo human skin and in vivo using minipigs. The MN patches are based on biodegradable polymers and the active pharmaceutical ingredients calcipotriol (Calci) and betamethasone-17-21-dipropionate (BDP) used to treat psoriasis. Using computed tomography (CT) and Coherent anti-Stokes Raman scattering (CARS) microscopy it was possible to visualize the skin penetration and follow the morphology of the MN as function of time in the skin. The depot effect was assessed by studying the modified in vitro release in an aqueous buffer and by comparing the drug release of a single application of a patch both ex vivo and in vivo to daily application of a marketed oleogel containing the same active pharmaceutical ingredients. The CT and CARS images showed efficient penetration of the MN patches into the upper dermis and a slow swelling process of the drug containing tip over a period of 8 days. Furthermore, CARS demonstrated that it can be used as a noninvasive technique with potential applicability in clinical settings. The in vitro release studies show a release of 54% over a time period of 30 days. The pharmacological relevance of MNs was confirmed in human skin explants and in vivo after single application and showed a similar response on calcipotriol and BDP mediated signaling events compared to daily application of the active oleogel. Altogether it was demonstrated that the MN can penetrate the skin and have the potential to provide a depot effect.

Printable Personalized Drug Delivery Patch for the Topical Therapy of Skin Diseases

Fabrication of Patterned Three-Dimensional Micron Scaled Core-Sheath Architectures for Drug Patches

3D Printed Ion-Responsive Personalized Transdermal Patch

Application of microneedle patches for drug delivery; doorstep to novel therapies

Hard polymeric porous microneedles on stretchable substrate for transdermal drug delivery

Numerical simulation of transdermal delivery of drug nanocarriers using solid microneedles and medicated adhesive patch

Multifunctional Microneedle Patches via Direct Ink Drawing of Nanocomposite Inks for Personalized Transdermal Drug Delivery

Codelivery of hydrophilic and hydrophobic drugs in a microneedle patch for the treatment of skin pigmentation

3D-Printed Products for Topical Skin Applications: From Personalized Dressings to Drug Delivery

A universal powder-laden crosslinked chitosan microneedle patch for high-dose controllable drug delivery

Iontophoresis-driven porous microneedle array patch for active transdermal drug delivery

Latest development and versatile applications of highly integrating drug delivery patch

Multi-material 3D printed eutectogel microneedle patches integrated with fast customization and tunable drug delivery

Photothermal Responsive Microspheres‐Triggered Separable Microneedles for Versatile Drug Delivery

Biocompatible All-in-One Adhesive Needle-Free Cup Patch for Enhancing Transdermal Drug Delivery

Versatile Platforms of Microneedle Patches Loaded with Responsive Nanoparticles: Synthesis and Promising Biomedical Applications

Self‐Healing Porous Microneedles Fabricated Via Cryogenic Micromoulding and Phase Separation for Efficient Loading and Sustained Delivery of Diverse Therapeutics

Multilayered Pyramidal Dissolving Microneedle Patches with Flexible Pedestals for Improving Effective Drug Delivery

Digital automation of transdermal drug delivery with high spatiotemporal resolution

Dissolvable microneedles for transdermal drug delivery showing skin pentation and modified drug release

Near‐infrared Triggered Biodegradable Microneedle Patch for Controlled Macromolecule Drug Release